Close
Nordic 9Nordic 9

Rejuveron Life Sciences (private company)

Switzerland rejuveron.com
See something wrong or missing? Let us know
Offices:Zurich
Industry:BiotechFinancial ServicesHealth servicesPharma
Business model:B2B

Rejuveron Life Sciences is a Swiss biotech startup developing a fully integrated biotechnology platform that invests in people and ideas to develop therapies.

Investors: we tracked 9 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 100.31M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Rejuveron Life Sciences

Name Criteria
Denmark NMD Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Synklino
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 5
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Cardior Pharmaceuticals
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 6
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom PetMedix
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Germany Emergence Therapeutics
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Pear Bio
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Belgium Precirix
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 6
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Top